参考文献/References:
[1]魏晓蕾,赵向辉.胺碘酮与西地兰治疗急诊危重症合并快速心律失常的效果比较[J].中国校医,2020,34(12):49-51.[2]戴晓金,杨雪平.胺碘酮与西地兰治疗急诊危重症合并快速心律失常的效果对比[J].中外医学研究,2019,17(35):47-49.[3]李雪源.冠心病室性心律失常患者的药物治疗分析[J].中西医结合心血管病电子杂志,2020,8(32):39-40.[4]牛明钊.美托洛尔联合胺碘酮治疗冠心病慢性心力衰竭合并室性心律失常的临床效果研究[J].中国现代药物应用,2020,14(22):130-132.[5]宋欢欢,缪丹丹,张宁,等.胺碘酮联合β受体阻滞剂治疗急性心肌梗死并发的快速心律失常临床效果观察[J].航空航天医学杂志,2020,31(11):1362-1363.[6]黄安丽,张春园.西地兰在阵发性室上性心动过速急诊治疗中的应用[J].北方药学,2020,17(2):101-102.[7]梁红军.胺碘酮联合中药治疗冠心病快速心律失常的效果分析[J].河南医学研究,2018,27(4):710-711.[8]李建成.急诊应用胺碘酮治疗冠心病快速心律失常的临床疗效分析[J].中国社区医师,2018,34(27):63,65.[9]吴忠承.急诊应用胺碘酮治疗冠状动脉粥样硬化性心脏病合并快速心律失常的疗效[J].中国药物经济学,2018,13(9):85-87.[10]赵丽.比较去乙酰毛花苷注射液、胺碘酮治疗急诊危重症合并快速心律失常的临床效果[J].系统医学,2020,5(21):40-42.[11]梅道菊.胺碘酮对危重症并快速心律失常患者心功能的影响[J].深圳中西医结合杂志,2020,30,257(4):141-142.[12]Mujovic N,Dobrev D,Marinkovic M,et al.The role of amiodarone in contemporary management of complex cardiac arrhythmias[J].Pharmacol Res,2020(151):104521. [13]何新为,陈加仕,郭勤生.西地兰注射液在急性心肌梗死合并急性心力衰竭再灌注后早期的应用效果[J].中华灾害救援医学,2019,7(11):27-29.[14]王倩英.小剂量胺碘酮联合倍他乐克治疗肥厚型心肌病伴恶性室性心律失常对心电图指标及预后的影响[J].中国合理用药探索,2018(6):29-32.[15]张声飞.西地兰和胺碘酮对急诊危重症患者伴快速心律失常及心功能改善的临床疗效比较[J].抗感染药学,2018,15(7):153-155.[16]韩文丽,王胜利,王珍鱼.小剂量胺碘酮与倍他乐克联合治疗冠心病伴恶性室性心律失常的效果[J].中国实用医刊,2018(22):125-126.[17]杨洪.小剂量胺碘酮与倍他乐克联合治疗肥厚型心肌病伴恶性室性心律失常的效果及不良反应发生率分析[J].中国医药指南,2019,17(16):133-134.[18]楚轶,卢少平,程锦,等.胺碘酮联合美托洛尔治疗冠心病合并心律失常临床研究[J].湖南师范大学学报(医学版),2016,13(5):20-21,22.[19]Pokorney SD,Holmes DN,Shrader P,et al.Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation[J]. Am Heart J,2020(220):145-154.
相似文献/References:
[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Medical Information,2018,31(20):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Medical Information,2018,31(20):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[3]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Medical Information,2018,31(20):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[4]张 旭.冠心病心绞痛患者进行护理干预的临床效果及
对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Medical Information,2018,31(20):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
[5]向明明,赵晓辉.黑龙江省东部地区汉族人群冠心病的危险因素研究[J].医学信息,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
XIANG Ming-ming,ZHAO Xiao-hui.Study on Risk Factors of Coronary Heart Disease in Han Nationality Population in Eastern Heilongjiang Province[J].Medical Information,2018,31(20):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
[6]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与
冠状动脉病变程度的关系[J].医学信息,2018,31(08):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Medical Information,2018,31(20):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
[7]毛红岩.冠状动脉介入治疗冠心病的疗效及
对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Medical Information,2018,31(20):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[8]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与
冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Medical Information,2018,31(20):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[9]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Medical Information,2018,31(20):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[10]田跃雷.冠心病介入治疗后再狭窄的中西医防治[J].医学信息,2022,35(09):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
TIAN Yue-lei.Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine[J].Medical Information,2022,35(20):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
[11]张红新.归脾汤联合美托洛尔治疗冠心病合并心律失常的效果及预后[J].医学信息,2019,32(04):156.[doi:10.3969/j.issn.1006-1959.2019.04.051]
ZHANG Hong-xin.Effect and Prognosis of Guipi Decoction Combined with Metoprolol in the Treatment of Coronary Heart Disease Complicated with Arrhythmia[J].Medical Information,2019,32(20):156.[doi:10.3969/j.issn.1006-1959.2019.04.051]
[12]师存莉,陈 蓉.阿托伐他汀联合冠心舒通胶囊对糖尿病合并冠心病患者心律失常的疗效及对血脂与凝血功能的影响[J].医学信息,2022,35(06):159.[doi:10.3969/j.issn.1006-1959.2022.06.041]
SHI Cun-li,CHEN Rong.Effect of Atorvastatin Combined with Guanxinshutong Capsule on Arrhythmia and Blood Lipid and Coagulation Function in Diabetic Patients with Coronary Heart Disease[J].Medical Information,2022,35(20):159.[doi:10.3969/j.issn.1006-1959.2022.06.041]
[13]贾慧芳.12导联动态心电图、常规心电图在无症状冠心病心肌缺血伴发心律失常诊断中的价值[J].医学信息,2023,36(11):126.[doi:10.3969/j.issn.1006-1959.2023.11.025]
JIA Hui-fang.The Value of 12-lead Holter Electrocardiogram and Routine Electrocardiogram in the Diagnosis of Myocardial Ischemia with Arrhythmia in Asymptomatic Coronary Heart Disease[J].Medical Information,2023,36(20):126.[doi:10.3969/j.issn.1006-1959.2023.11.025]